More on CRVS
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $14.71 |
|
|||
| Open | $14.71 | ||||
| 52 Wk High | $17.77 | ||||
| 52 Wk Low | $9.63 | ||||
| Day High | $14.71 | ||||
| Day Low | $14.71 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 348 | ||||
- Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: Moore David Scott
- Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: CLARK IAN T
- Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: Grais Linda
- Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: Thompson Peter A.
- Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: van den Broek Richard
- Form 8-K Corvus Pharmaceuticals, For: Jun 11
- Corvus Pharmaceuticals invests $5 million in Angel Pharmaceuticals
- Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China
- Form 4 Corvus Pharmaceuticals, For: May 18 Filed by: MILLER RICHARD A MD
- Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
Entities mentioned with CRVS
- FDA | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Jefferies & Co | View Related Stories »
- OrbiMed Advisors | View Related Stories »
- Show More...
